Udg Healthcare (UDHCF) Rating Lowered to Hold at Zacks Investment Research

Udg Healthcare (OTCMKTS:UDHCF) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday, January 6th. They currently have a $13.00 target price on the stock. Zacks Investment Research‘s target price would suggest a potential upside of 10.73% from the company’s previous close.

According to Zacks, “UDG Healthcare plc provide services to the healthcare industry. The company’s operating segment consists of Ashfield Commercial & Medical Services, Sharp Packaging Services and Supply Chain Services. Ashfield Commercial & Medical Services division provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services. Sharp Packaging Service division provides contract packaging and clinical trial packaging services. Supply Chain Services provides outsourced sales, marketing, distribution and engineering services. UDG Healthcare plc operates primarily in US, UK, Ireland and Germany. UDG Healthcare plc is based in Dublin, the Republic of Ireland. “

Shares of Udg Healthcare (OTCMKTS UDHCF) opened at $11.74 on Friday. Udg Healthcare has a fifty-two week low of $8.01 and a fifty-two week high of $12.65.

ILLEGAL ACTIVITY NOTICE: This piece was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright legislation. The correct version of this piece can be viewed at https://ledgergazette.com/2018/01/13/udg-healthcare-udhcf-cut-to-hold-at-zacks-investment-research.html.

About Udg Healthcare

UDG Healthcare plc, together with its subsidiaries, provides clinical, commercial, communication, and packaging services to the healthcare industry in the Republic of Ireland, the United Kingdom, North America, and continental Europe. It operates through three segments: Ashfield, Sharp, and Aquilant.

Get a free copy of the Zacks research report on Udg Healthcare (UDHCF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply